Annals of Internal Medicine, Ahead of Print.
Risultati per: Screening della retinopatia diabetica
Questo è quello che abbiamo trovato per te
Patient Information: Screening for Anxiety in Children and Adolescents
This JAMA Patient Page summarizes the US Preventive Services Task Force’s recent recommendations on screening for anxiety in children and adolescents.
Screening for Pediatric Anxiety Disorders
In this issue of JAMA, the US Preventive Services Task Force (USPSTF) presents a Recommendation Statement on screening for anxiety in children and adolescents, based on an Evidence Report and Systematic Review by Viswanathan et al that summarized the evidence for screening and treatment. In its current report, the USPSTF “recommends screening for anxiety in children and adolescents aged 8 to 18 years (B recommendation)” and “concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger (I statement).”
USPSTF Recommendation: Screening for Anxiety in Children and Adolescents
This 2022 Recommendation Statement from the US Preventive Services Task Force recommends screening for anxiety in children and adolescents aged 8 to 18 years (B recommendation) and concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger (I statement).
USPSTF Report: Screening for Anxiety in Children and Adolescents
This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on screening for anxiety in children and adolescents summarizes published evidence on the benefits and harms of screening for and treatment of anxiety in children and adolescents 18 years or younger.
Understanding the Results of a Randomized Trial of Screening Colonoscopy
New England Journal of Medicine, Ahead of Print.
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
New England Journal of Medicine, Ahead of Print.
Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance
The Asia-Pacific region has the largest number of cases of colorectal cancer (CRC) and one of the highest levels of mortality due to this condition in the world. Since the publishing of two consensus recommendations in 2008 and 2015, significant advancements have been made in our knowledge of epidemiology, pathology and the natural history of the adenoma-carcinoma progression. Based on the most updated epidemiological and clinical studies in this region, considering literature from international studies, and adopting the modified Delphi process, the Asia-Pacific Working Group on Colorectal Cancer Screening has updated and revised their recommendations on (1) screening methods and preferred strategies; (2) age for starting and terminating screening for CRC; (3) screening for individuals with a family history of CRC or advanced adenoma; (4) surveillance for those with adenomas; (5) screening and surveillance for sessile serrated lesions and (6) quality assurance of screening programmes. Thirteen countries/regions in the Asia-Pacific region were represented in this exercise. International advisors from North America and Europe were invited to participate.
Endoscopist characteristics and polyp detection in colonoscopy: cross-sectional analyses of Screening of Swedish Colons
Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended
This cohort study of data on participants in the Cardiovascular Health Study assesses risk of lung cancer in smokers for whom low-density computed tomographic screening is not recommended.
Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Black and White US Veterans
This cohort study uses US Veterans Health Administration data to assess the association of prostate-specific antigen screening with prostate cancer–specific mortality among non-Hispanic Black men and non-Hispanic White men.
Screening and management of sleep disorders in patients with fibromyalgia syndrome: a French multicentred, prospective, observational study protocol (FIBOBS)
Introduction
Sleep disorders are still often underestimated in patient care management even though they are present in the criteria of the American College of Rheumatology for the diagnosis of fibromyalgia syndrome (FMS). The objective of this study will be to assess the current situation of sleep disorders in patients with FMS in France and to estimate its prevalence.
Methods and analysis
The FIBOBS study is a multicentred, prospective, observational trial performed by 46 specialised chronic pain structures in France. Patients with FMS visiting for a first consultation or follow-up (if they have already been followed up for less than a year with a pain management service) will be included after giving their informed consent. Data will be collected through the physician questionnaire filled during the inclusion visit. Patient self-questionnaires will be completed from home. The primary outcome of the study will be to estimate the prevalence of sleep disorders classified into three categories: (a) poor sleep quality in general, (b) sleep apnoea syndrome and (c) restless legs syndrome, using self-administered questionnaires.
Ethics and dissemination
This protocol is approved by the ethics committee Comité de Protection des Personnes ‘Ile de France II’ in accordance with French regulations. The results will be disseminated through peer-reviewed journals and conferences.
Trial registration number
NCT04775368.
Serial Bone-Mineral Density Screening in Men
Fracture prediction is not improved significantly by repeat BMD measurement.
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines
Annals of Internal Medicine, Ahead of Print.
Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test–Based Screening
Annals of Internal Medicine, Volume 175, Issue 10, Page 1366-1373, October 2022.
Cancer Screening Guidelines Are Not Simple, But They Could Be Less Complex
Annals of Internal Medicine, Ahead of Print.